Skip to content

Binge Eating Syndrome Treatment for Older Women (BESTOW)

Binge Eating Syndrome Treatment for Older Women (BESTOW)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05806788
Acronym
BESTOW
Enrollment
20
Registered
2023-04-10
Start date
2023-02-17
Completion date
2023-11-14
Last updated
2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating

Keywords

Binge Eating Spectrum, Cognitive-behavioral therapy, Body Image

Brief summary

Twenty women, ages 60 or older, will be consented and enrolled in a single-arm, pilot implementation trial of the age-tailored cognitive-behavioral based BE intervention. Participants will complete assessments at baseline, post-intervention, and at two follow-up timepoints; weekly BE frequency will be collected to monitor progress during the intervention period.

Detailed description

The intervention being studied will be an age-tailored, cognitive-behavioral therapy (CBT) based behavioral intervention for binge eating (BE), delivered by the PI, a licensed clinical psychologist, in small group format (4-6 participants per group) over 12-16 weeks. The intervention will utilize behavioral-based strategies to reduce BE and improve health behaviors, with content including strategies to improve body image, regulation of eating behaviors, and integration of physical activity with an emphasis on body function, health, and longevity. The final session number, frequency, content, and timeline will be determined during intervention-tailoring process not a part of this clinical trial.

Interventions

BEHAVIORALBinge Eating Syndrome Treatment (BESTOW)

The BESTOW program involves discussions as well as written and behavioral activities. Participants will also be asked to complete activities, or 'homework,' in between sessions that will help to stop binge eating and to improve eating habits.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study is a beta-testing of a new behavioral intervention treatment - all participants will be assigned to the treatment and give feedback on the treatment throughout the study.

Eligibility

Sex/Gender
FEMALE
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women * Age 60 years and over * Binge eating (BE) ≥1/week during the past ≥3 months * Community-dwelling * Able to provide informed consent * Consistent medication regimen for 3 months

Exclusion criteria

* Significant cognitive impairment * Nursing home, long-term care facility * Psychosis or imminent suicide risk * Current BE treatment

Design outcomes

Primary

MeasureTime frameDescription
Feasibility - Usage Rating Profile - Intervention6 weeks (post), and 2 month follow-upScore on the Feasibility Usage Rating Profile. This scale gathers patient reported feasibility of the intervention (e.g., time needed, quality of materials, simplicity of the intervention) to be completed after doing the intervention. This scale has six items; total scores range from 1-6 and a higher scores indicate greater feasibility.
Acceptability - Usage Rating Profile - Intervention6 weeks (post), and 2 month follow-upScore on the Acceptability Usage Rating Profile scale which gathers participant ratings of how acceptable the treatment is for targeting binge eating (e.g., how helpful the intervention was, how much they liked it, willingness to do the intervention) to be completed after doing the intervention. This scale has eight items; total scores range from 1-6, a higher score indicates greater acceptability.

Secondary

MeasureTime frameDescription
Binge Eating Score (BES)Baseline, 6 weeks, 1 month, and 2 month follow-upChange in score on the BES survey. The BES is a 16-item, self-report survey that assess binge eating. Total scores range from 0 to 46, with higher scores meaning more severe binge eating symptoms (Gormally et al., 1982).
Geriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)Baseline, 6 weeks (post), 1 month, and 2 month follow-upThe CES-D is a 10-item, self-report survey that assess depressive symptoms. Mean scores range from 0 to 3, with higher scores indicating more depressive symptoms (Lewinsohn et al., 1997).

Countries

United States

Participant flow

Participants by arm

ArmCount
BESTOW Behavioral Intervention
The intervention will utilize behavioral-based strategies to reduce BE and improve health behaviors, with content including strategies to improve body image, regulation of eating behaviors, and integration of physical activity with an emphasis on body function, health, and longevity. Binge Eating Syndrome Treatment (BESTOW): The BESTOW program involves discussions as well as written and behavioral activities. Participants will also be asked to complete activities, or 'homework,' in between sessions that will help to stop binge eating and to improve eating habits.
20
Total20

Baseline characteristics

CharacteristicBESTOW Behavioral Intervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
9 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
Age, Continuous65.3 years
STANDARD_DEVIATION 4.97
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Acceptability - Usage Rating Profile - Intervention

Score on the Acceptability Usage Rating Profile scale which gathers participant ratings of how acceptable the treatment is for targeting binge eating (e.g., how helpful the intervention was, how much they liked it, willingness to do the intervention) to be completed after doing the intervention. This scale has eight items; total scores range from 1-6, a higher score indicates greater acceptability.

Time frame: 6 weeks (post), and 2 month follow-up

Population: Post-assessment completers

ArmMeasureGroupValue (MEAN)Dispersion
BESTOW Behavioral InterventionAcceptability - Usage Rating Profile - Intervention6 weeks (post assessment)5.58 score on a scaleStandard Deviation 0.75
BESTOW Behavioral InterventionAcceptability - Usage Rating Profile - Intervention2-month follow-up5.50 score on a scaleStandard Deviation 0.76
Primary

Feasibility - Usage Rating Profile - Intervention

Score on the Feasibility Usage Rating Profile. This scale gathers patient reported feasibility of the intervention (e.g., time needed, quality of materials, simplicity of the intervention) to be completed after doing the intervention. This scale has six items; total scores range from 1-6 and a higher scores indicate greater feasibility.

Time frame: 6 weeks (post), and 2 month follow-up

Population: Post-assessment completers

ArmMeasureGroupValue (MEAN)Dispersion
BESTOW Behavioral InterventionFeasibility - Usage Rating Profile - Intervention6 weeks (Post intervention)5.44 score on a scaleStandard Deviation 0.85
BESTOW Behavioral InterventionFeasibility - Usage Rating Profile - Intervention2-month follow-up5.53 score on a scaleStandard Deviation 0.83
Secondary

Binge Eating Score (BES)

Change in score on the BES survey. The BES is a 16-item, self-report survey that assess binge eating. Total scores range from 0 to 46, with higher scores meaning more severe binge eating symptoms (Gormally et al., 1982).

Time frame: Baseline, 6 weeks, 1 month, and 2 month follow-up

Population: Completers. One of the subjects was too busy to complete the questionnaire at the 1 month follow up, so only 16 participants were evaluable at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
BESTOW Behavioral InterventionBinge Eating Score (BES)Baseline24.78 score on a scaleStandard Deviation 5.89
BESTOW Behavioral InterventionBinge Eating Score (BES)Post14.81 score on a scaleStandard Deviation 5.87
BESTOW Behavioral InterventionBinge Eating Score (BES)1-month follow-up13.24 score on a scaleStandard Deviation 6.64
BESTOW Behavioral InterventionBinge Eating Score (BES)2-month follow-up13.81 score on a scaleStandard Deviation 9.08
Secondary

Geriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)

The CES-D is a 10-item, self-report survey that assess depressive symptoms. Mean scores range from 0 to 3, with higher scores indicating more depressive symptoms (Lewinsohn et al., 1997).

Time frame: Baseline, 6 weeks (post), 1 month, and 2 month follow-up

Population: Completers. One of the subjects was too busy to complete the questionnaire at the 1 month follow up, so only 16 participants were evaluable at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
BESTOW Behavioral InterventionGeriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)Baseline1.15 score on a scaleStandard Deviation 0.59
BESTOW Behavioral InterventionGeriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)Post0.91 score on a scaleStandard Deviation 0.75
BESTOW Behavioral InterventionGeriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)1-month follow-up0.93 score on a scaleStandard Deviation 0.69
BESTOW Behavioral InterventionGeriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)2-month follow-up1.00 score on a scaleStandard Deviation 0.81

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026